期刊文献+

调肝降浊灌肠汤治疗慢性肾功能不全临床观察 被引量:3

Clinical Observation of Tiaoganjiangzhuo Guanchang Soup for the treatment of Chronic Renal Failure
下载PDF
导出
摘要 目的:探讨中药调肝降浊灌肠汤保留灌肠治疗慢性肾功能不全(CRF)的临床疗效。方法:60例CRF患者随机分为灌肠组(A组)30例,使用调肝降浊灌肠汤保留灌肠;对照组(B组)30例,予科素亚50mg/d,口服,每日1次。均以2w为1个疗程。分别观察其临床症状、尿素氮、肌酐及肌酐清除率变化。结果:A组治疗后症状评分、BUN、Scr水平均较治疗前明显降低,肌酐清除率较治疗前明显升高(P<0.05);B组治疗后症状评分、Scr水平较治疗前明显降低,肌酐清除率较治疗前明显升高(P<0.05),治疗前后尿素氮比较差异不显著。两组间症状和肾功能的改善水平相当。结论:中药复方调肝降浊灌肠汤保留灌肠与科素亚均可改善临床症状,降低增高的血清肌酐,提高肌酐清除率,从而起到延缓慢性肾功能衰竭进展,保护肾功能的目的。 Objective.To observe the clinical effect of Tiaoganjiangzhuo Guanchang Decoction for treatment of chronic renal failure (CRF). Methods: 60 patients with CRF were divided into two groups randomLy, the therapeutic group and the control group. Patients in the therapeutic group (A group 30 cases) were administered with Tiaoganjiangzhuo Guanchang Soup, while those in the control group (B group 30 cases) treated with Lostan(50 mg,qd po). The time of treatment was two weeks. The changes of clinical symptoms.BUN .Scr and Ccr before and after the treatment were observed. Results: Accumulated score of clinical symptoms.BUN and Scr were remarkably decreased after treatment with Tiaoganjiangzhuo Guanchang Soup, while Ccr was remarkably rise(P〈0.05) ; Accumulated score of clinical symptoms and Scr were remarkably decreased after treatment with Lostan,while Ccr was remarkably rise(P〈0.05) ,but the changes of BUN was not significant. There was no significant difference between the two groups. Conclusion:Both compound of Tiaoganjiangzhuo Guanchang Decoction and Lostan could improve clinical symptoms,desend the rised Scr and asend the decreased Ccr. So that they could delay improvement of CRF and protect renal founction.
出处 《世界中西医结合杂志》 2007年第4期226-228,共3页 World Journal of Integrated Traditional and Western Medicine
基金 上海市长宁区卫生局科研基金项目资助(20054Y04001)
关键词 调肝降浊汤 保留灌肠 慢性肾功能不全 Tiaoganjiangzhuo Soup enema renal founction
  • 相关文献

参考文献3

二级参考文献32

  • 1崔彤霞,汪涛.血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂在肾脏病的应用[J].中国中西医结合肾病杂志,2000,1(1):62-64. 被引量:4
  • 2李幼姬,曾丽霞.恩纳普利在肾脏病领域中的应用──—肾脏病临床选萃(6)[J].新医学,1995,26(11):604-605. 被引量:3
  • 3SmithRD,Timmermans PBMWM.Humon angiotensin receptor types.Curropin Nephrol Hypertens,1994,3:112.
  • 4Fernandez Andrade C,Russo D,Iversen B,et al.Comparison of losartan and amlodipine and amlodipine in renally impaired hypertensive patients,1998,68:120-124.
  • 5Gansevoort RT,de-ZeeuwD,Shahinfar S.Effects of the angiotensin Ⅱ antagonist losartan in hypertensine with renal diease.J Hypertens Suppl,1994,12(2):37.
  • 6Remuzzi A, Perico N, Sangalli F,et al. ACE inhibition and AngⅡ recep-tor blockade improve glomerular Size-selectinicy in IgA nephropathy. Am J Physiol,1999,276:457.
  • 7yoshiokaT,RennkeHG,SalantDJ,et.al.Roleofabnormallyhightransmuralpressureinthepermselectivitydefectofglomerularcapillarywall:AstudyinearlyHeymannnephritis.CircRes.1987;61:531
  • 8Gansevoort,RT,SLuiter,WJ,Hemmelder,MH,etal.Antiproteinurieeffectofblood-pressute-loweringagents:Ameta-analysisofcomparativetrials.NephrolDialTransplant.1995;10:1963
  • 9Heeg,JE,deJongPE,VanderHem,GK,dezeeuw,D.EfficacyandVariabilityoftheantiproteinuziceffectofACEinhibitionbylisinopril.KidneyInt.1989;36:272
  • 10Appedoo,AJ,dezeeuw,D,Sluiter,HE,deJong,PE.Differentialeffectsofenalaprilandatenololonproteinuacandrenalhaemodynamiesinnon-diabeticrenaldisease.BMJ.1991;303:821

共引文献95

同被引文献45

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部